OCUGEN INC
OCGN · NASDAQ
Updated at 2026-10-13 14:53:59
- Today's High
- $0.95
- Today’s Low
- $0.89
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.95
- Previous Close
- $0.94
- Volume
- 3.27M
- Market Cap
- $321.2M
- P/E Ratio
- --
- EPS
- $-0.19
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, UNITED STATES, 19355
- Country
- US
- Listing Date
- 2014-12-03
- Fiscal Year End
- December
- Shares Outstanding
- 338.52M
- CIK
- 0001372299
- Website
- ocugen.com
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.
Financial Metrics
Revenue
2026-06-30
$1.48M
2026-03-31
$1.53M
2025-12-31
-$193K
2025-09-30
$1.75M
Operating Expenses
2026-06-30
$17.93M
2026-03-31
$19.37M
2025-12-31
$16.8M
2025-09-30
$19.37M
Net Income
2026-06-30
-$24.87M
2026-03-31
-$19.17M
2025-12-31
-$17.7M
2025-09-30
-$20.05M
Net Profit Margin
2026-06-30
-1.67K%
2026-03-31
-1.25K%
2025-12-31
9.17K%
2025-09-30
-1.14K%
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
$-0.06
2025-12-31
$-0.06
2025-09-30
$-0.07
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$19.81M
2026-03-31
-$17.26M
2025-12-31
-$15.25M
2025-09-30
-$17.78M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.48M | $1.53M | -$193K | $1.75M |
| Operating Expenses | $17.93M | $19.37M | $16.8M | $19.37M |
| Net Income | -$24.87M | -$19.17M | -$17.7M | -$20.05M |
| Net Profit Margin | -1.67K% | -1.25K% | 9.17K% | -1.14K% |
| Earnings Per Share | $-0.07 | $-0.06 | $-0.06 | $-0.07 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$19.81M | -$17.26M | -$15.25M | -$17.78M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.